Crossref

1. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

- Yan Xue

- Li-Xin Zhang

- Lei Wang

- Tao Li

- Yun-Dong Qu

- Feng Liu

2. Efficacy and safety of sofosbuvir‐based interferon‐free therapies for hepatitis C in liver transplant recipients

- Yundong Qu

- Ying Guo

- Tao Li

- Qian Ye

- Chao Sun

- Lei Wang

- Baohua Yang

3.

4. RETRACTED ARTICLE: Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice

- Sherief Abd-Elsalam

- Mohamed Sharaf-Eldin

- Shaimaa Soliman

- Asem Elfert

- Rehab Badawi

- Youssef K. Ahmad

5. Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India

- Narendra S. Choudhary

- Sanjiv Saigal

- Dheeraj Gautam

- Neeraj Saraf

- Amit Rastogi

- Sanjay Goja

- Prashant Bhangui

- Arvinder S. Soin

6. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis

- Mohammad Saeid Rezaee-Zavareh

- Khashayar Hesamizadeh

- Heidar Sharafi

- Seyed Moayed Alavian

7. Treatment of Patients With Hepatitis C Virus Infection With Ledipasvir-Sofosbuvir in the Liver Transplant Setting

- Faisal Abaalkhail

- Hussein Elsiesy

- Hany Elbeshbeshy

- Mohamed Shawkat

- Sarra Yousif

- Waheed Ullah

- Saleh Alabbad

- Ahmed Al-jedai

- Aziza Ajlan

- Dieter Broering

- Sammy Saab

- Mohammed Al Sebayel

- Waleed Al-Hamoudi

8. Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?

- Iman F. Montasser

- Mohamed A. Sakr

- Hany M. Dabbous

- Kareem Abdelaziz

- Hend Ebada

- Yasmine M. Massoud

- Mohamed Bahaa

- Hany Said

- Kamal Mamdouh

- Mahmoud S. El Meteini